Studies thinking and memory changes after stroke
Looks at which factors affect memory and thinking after a stroke in adults.
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Ann Arbor, Baltimore, Boston, Charlottesville, Chicago, Cincinnati, Denver, Durham, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Los Angeles, Memphis, Miami, Minneapolis, New York, Philadelphia, Phoenix, Rochester, Salt Lake City, San Antonio, San Diego, Seattle, The Bronx, and Winston-Salem, United StatesSee the 31 sites
- Trial code
- Registry title
- Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
- Status
- Recruiting
- People taking part
- 8,000 people, planned
- Started
- 5 Mar 2021
- Expected to end
- 31 Aug 2027
- Type of study
- Observational
- Record updated
- 14 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who were in hospital with a recent stroke (a blood clot in the brain, bleeding in the brain, or bleeding around the brain from a burst aneurysm). It studies thinking and memory after stroke.
- Age
- 18 years or older. For Tier 3 participants, 50 years or older.
- Sex
- All sexes can join.
- Disease stage
- Acute ischemic stroke, intracerebral hemorrhage, or aneurysmal subarachnoid hemorrhage, confirmed on brain imaging. The baseline visit must be done within 6 weeks of stroke onset.
Main reasons for not taking part
- Known dementia before the stroke, or failing the dementia pre-screen
- Taking part in another study not approved under the DISCOVERY Co-Enrollment Policy
- Unable to complete the study, for example comfort measures only or severe medical or behavioral conditions
- Tier 2: implants or metal clips in the brain that do not allow MRI
- Tier 3: pregnant or seeking to become pregnant, or certain genetic conditions that raise cancer risk, including Down's syndrome
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age ≥18 years
- Admitted to the enrolling clinical performance site (CPS) hospital with a diagnosis of acute ischemic stroke (AIS), intracerebral hemorrhage (ICH), or aneurysmal subarachnoid hemorrhage (aSAH)
- Radiographic confirmatory evidence of: (1) AIS (based on a focal area of restricted diffusion on MRI), (2) non-traumatic primary ICH (based on evidence of acute parenchymal hemorrhage on CT or brain MRI) or (3) non-traumatic acute aSAH (based on evidence of subarachnoid hemorrhage on CT or MRI and evidence of aneurysm on CT angiography, MR angiography, or conventional catheter-based angiography)
- Able to complete baseline visit in person or by phone within 6 weeks of stroke onset
- Able to provide informed consent by self or proxy
- Fluent in English or Spanish prior to stroke onset
Who cannot take part
- Documented history of pre-stroke dementia or fails dementia pre-screen
- Contraindication to MRI: presence of electrically, magnetically, or mechanically activated implants (such as cardiac pacemakers, cochlear implants, implanted pumps); or metallic clips in the brain; Additional exclusion criteria for Tier 3 participants:
- Known to have one of the following genetic conditions which can increase the risk of developing cancer: Cowden disease, Lynch syndrome, hypogammaglobulinemia, Wiskott-Aldrich syndrome, Down's syndrome
- Age <50 years
- Concurrently enrolled into a study that is not approved under the DISCOVERY Co-Enrollment Policy
- Unable to complete study protocol (advanced directives such as comfort measures only, or inability to complete the study due to severe medical/behavioral co-morbidities), as determined by physician investigator during screening process; Additional exclusion criteria for Tier 2 participants:
- Biologically female individuals who are pregnant or seeking to become pregnant
Where in United States
- University of MichiganAnn Arbor, United StatesContact: James Meschia, MDNo longer taking part
- University of Maryland Medical CenterBaltimore, United StatesContact: Gunjan Parikh, MDTaking people
- Boston Medical CenterBoston, United StatesContact: Hugo Aparicio, MD, MPHTaking people
- Massachusetts General HospitalBoston, United StatesContact: Natalia Rost, MDTaking people
- University of VirginiaCharlottesville, United StatesContact: Bradford Worrall, MDTaking people
- The University of Chicago Medical CenterChicago, United StatesContact: Karen Orjuela, MD, MSTaking people
- University of CincinnatiCincinnati, United StatesContact: Stacie Demel, DO, PhDTaking people
- University of ColoradoDenver, United StatesContact: Jennifer Simpson, MDTaking people
- Duke University Medical CenterDurham, United StatesContact: Nada El Husseini, MD, MHSTaking people
- Houston Methodist Research InstituteHouston, United StatesContact: Rajan Gadhia, MDTaking people
- UTHealthHouston, United StatesContact: Sean Savitz, MDTaking people
- Indiana UniversityIndianapolis, United StatesContact: Jason Mackey, MDTaking people
- University of IowaIowa City, United StatesContact: James Meschia, MDNo longer taking part
- University of Mississippi Medical CenterJackson, United StatesContact: Syed Hussain, MDTaking people
- Mayo ClinicJacksonville, United StatesContact: Michelle Lin, MD, MPHTaking people
- Cedars-Sinai Medical CenterLos Angeles, United StatesContact: Shlee Song, MDTaking people
- Kaiser Permanente Los Angeles Medical CenterLos Angeles, United StatesContact: Navdeep Sangha, MDTaking people
- University of California, Los AngelesLos Angeles, United StatesContact: Jason Hinman, MDTaking people
- Methodist University HospitalMemphis, United StatesContact: Balaji Krishnaiah, MDTaking people
- University of Miami Health SystemMiami, United StatesContact: Nicole Sur, MDTaking people
- University of Minnesota HealthMinneapolis, United StatesContact: Kamakshi Lakshminarayan, MD, PhD, MSTaking people
- Icahn School of Medicine at Mount SinaiNew York, United StatesContact: Michael Waters, MD, PhDTaking people
- The Hospital of the University of PennsylvaniaPhiladelphia, United StatesContact: Kelly Sloane, MDTaking people
- Barrow Neurological InstitutePhoenix, United StatesContact: Joyce Lee-Iannotti, MDTaking people
- Mayo ClinicRochester, United StatesContact: Eugene Scharf, MDTaking people
- University of UtahSalt Lake City, United StatesContact: Jennifer Majersik, MD, MSTaking people
- University of Texas Health Science Center at San AntonioSan Antonio, United StatesContact: Reza Behrouz, DOTaking people
- University of California San DiegoSan Diego, United StatesContact: Brett Meyer, MDTaking people
- University of Washington - Harborview Medical CenterSeattle, United StatesContact: Rizwan Kalani, MDTaking people
- Montefiore Medical CenterThe Bronx, United StatesContact: Daniel Labovitz, MDTaking people
- Wake Forest Baptist HealthWinston-Salem, United StatesContact: James Meschia, MDNo longer taking part
About the trial
What the trial wants to find out
The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking and other mental abilities that significantly affects daily functioning) after their stroke so that future treatments may be developed to improve outcomes in stroke patients. For this study, a "stroke" is defined as either (1) an acute ischemic stroke (AIS, or blood clot in the brain), (2) an intracerebral hemorrhage (ICH, or bleeding in the brain), (3) or an aneurysmal subarachnoid hemorrhage (aSAH, or bleeding around the brain caused by an abnormal bulge in a blood vessel that bursts).
Read full original descriptionShow less
The investigators hypothesize that:
1. The size, type and location of the stroke play an important role in recovery of thinking and memory abilities after stroke, and pre-existing indicators of brain health further determine the extent of this recovery. 2. Specific stroke events occurring in individuals with underlying genetic or biological risk factors can cause further declines in brain heath, leading to changes in thinking and memory abilities after stroke. 3. Studying thinking and memory alongside brain imaging and blood samples in patients who have had a stroke allows for earlier identification of declining brain health and development of individualized treatment plans to improve patient outcomes in the future.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
- Plain-language title
- Studies thinking and memory changes after strokeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 14 September 2026